Nuvaira, Inc.
Company Information
Industry
Founded Year
2008
Specialties
COPDPulmonologyobstructived lung diseaselung denervationobstructive lung diseaseInterventional Pulmonologychronic obstructive lung diseaseBronchoscopyLung Denervation, obstructive lung diseases, COPD
Overview
Nuvaira, Inc. develops innovative and groundbreaking therapies that aim to improve the lives of the more than 65 million people around the world with obstructive lung disease. Founded in 2008, Nuvaira was established to address clinical needs in the treatment of overactive airway nerves, a common disease feature of both COPD and asthma.
Nuvaira is a privately held medical device company, headquartered in Minneapolis, Minnesota USA and has more than 75 patents issued and pending worldwide.
The dNerva® Lung Denervation System is CE Mark approved. The dNerva® lung denervation system is under clinical investigation and is not commercially available in the USA.
Get Contact Info for All Employees
Steve Mertens
Sr. Vice President of R&D and Operations
Ryan Kaveckis
Director of Research and Development
Jonathan Black
Process Development Engineering Manager
Kristina Rouw
Principal Scientist
Melissa Ulberg
General Accountant
Start with AroundDeal For Free!
Instant access. Cancel anytime
Sign Up to View Nuvaira, Inc.’s Top Employees
Instant access. Cancel anytime
Similar Companies
Frequently Asked Questions Regarding Nuvaira, Inc.
Where is Nuvaira, Inc.'s headquarter located?
Nuvaira, Inc.'s headquarter located in United States.
What is Nuvaira, Inc. known for?
COPDPulmonologyobstructived lung diseaselung denervationobstructive lung diseaseInterventional Pulmonologychronic obstructive lung diseaseBronchoscopyLung Denervation, obstructive lung diseases, COPD
How many employees does Nuvaira, Inc. have?
11 - 50
What is Nuvaira, Inc. website?
http://nuvaira.com